1. The Influence of Intervening on the Pharmaceutical Consultation Targeting Outpatients with Advanced Non-small Cell Lung Cancer Receiving Erlotinib Treatment
   Seira Nishibe-Toyosato et al, 2021, Biological and Pharmaceutical Bulletin CrossRef
2. Evaluation of the Collaboration System between Community Pharmacies and Hospital for the Management of Oral Anti-cancer Therapy Using Information Sharing Tools and Team-based Learning
   Risa Ueda et al, 2020, Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) CrossRef
3. Survey of community and hospital pharmacist involvement in outpatient chemotherapy using Japanese health information data
   Mari Iwata et al, 2024, Journal of Pharmaceutical Policy and Practice CrossRef
4. Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis
   Haruna Yamamoto et al, 2018, Journal of Pharmaceutical Health Care and Sciences CrossRef
5. Analysis of Adverse Events Associated with Trastuzumab Deruxtecan in Patients with Gastric and Breast Cancer: A Retrospective Study
   Yuma Nonomiya et al, 2024, Biological and Pharmaceutical Bulletin CrossRef
6. An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer
   Mikito Mori et al, 2018, BMC Cancer CrossRef
7. The influence of pharmaceutical care in patients with advanced non-small-cell lung cancer receiving combination cytotoxic chemotherapy and PD-1/PD-L1 inhibitors
   Wen Kou et al, 2022, Frontiers in Pharmacology CrossRef
8. Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review
   Shoshana M Rosenberg et al, 2020, JNCI: Journal of the National Cancer Institute CrossRef
9. The impact of pharmacist‐led strategies implemented to reduce errors related to cancer therapies: a systematic review
   John Coutsouvelis et al, 2020, Journal of Pharmacy Practice and Research CrossRef